Longer-term virologic outcomes on tenofovir-lamivudine-dolutegravir in second-line ART (Southern African Journal of HIV Medicine, 2025)

(untitled) - van Heerden, JK; Zhao, Y; Keene, CM; Griesel, R; Omar, Z; Goliath, R; Delaney, K; van Zyl, G; Maartens, G; Meintjes, G